APA (7th ed.) Citation

Y, L., J, C., J, T., P, T., H, C., G, S., . . . L, S. (2025). Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism. The Journal of clinical investigation, 135(24), . https://doi.org/10.1172/JCI193082

Chicago Style (17th ed.) Citation

Y, Li, et al. "Leukemia-expanded Splenic CD81+ Erythroblasts Potentiate Disease Progression in Mice by Reshaping Leukemic Cell Metabolism." The Journal of Clinical Investigation 135, no. 24 (2025). https://doi.org/10.1172/JCI193082.

MLA (9th ed.) Citation

Y, Li, et al. "Leukemia-expanded Splenic CD81+ Erythroblasts Potentiate Disease Progression in Mice by Reshaping Leukemic Cell Metabolism." The Journal of Clinical Investigation, vol. 135, no. 24, 2025, https://doi.org/10.1172/JCI193082.